MAY
21
2020
ALL ARTICLES
Clinical trials in NZ worth $1.2 billion: Medicines NZ
New Zealand has a window of opportunity to increase market share.
Chief executive of Medicines NZ, Graeme Jarvis, says there has to be a collaborative effort between the industry, clinical research sector and government to make New Zealand a bigger player on the world stage.
Listen to Graeme discuss New Zealand’s clinical trials sector here.
New Zealand has a window of opportunity to increase market share.
Chief executive of Medicines NZ, Graeme Jarvis, says there has to be a collaborative effort between the industry, clinical research sector and government to make New Zealand a bigger player on the world stage.
Listen to Graeme discuss New Zealand’s clinical trials sector here.
ALL ARTICLES